Synthesis and evaluation of N-(4-(substituted)-3-(trifluoromethyl) phenyl) isobutyramides and their N-ethyl analogous as anticancer, anti-angiogenic & antioxidant agents: In vitro and in silico analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthesis and evaluation of N-(4-(substituted)-3-(trifluoromethyl) phenyl) isobutyramides and their N-ethyl analogous as anticancer, anti-angiogenic & antioxidant agents: In vitro and in silico analysis

Published:2021-06 Issue: Volume:92 Page:107484
ISSN:1476-9271
Container-title:Computational Biology and Chemistry
language:en
Short-container-title:Computational Biology and Chemistry

Author:

Sawant Ajay S.,Kamble Sonali S.,Pisal Parshuram M.,Sawant Sanjay S.,Hese Shrikant V.,Bagul Kamini T,Pinjari Rahul V.^ORCID,Kamble Vinod T.,Meshram Rohan J.,Gacche Rajesh N.

Publisher

Elsevier BV

Subject

Computational Mathematics,Organic Chemistry,Biochemistry,Structural Biology

Reference48 articles.

1. Design, synthesis and in silico study of pyridine based 1, 3, 4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent;Ambhore;Comput. Biol. Chem.,2019

2. Angiogenesis assays: a critical overview;Auerbach;Clin. Chem.,2003

3. Antiandrogenic activity of niphtolide produced by nitration of 3-trifluoromethyl isobutyranilide;Balyon;Khimiko-farmatsevticheskii zhurnal.,1991

4. Novel and gram‐scale green synthesis of flutamide;Bandgar;Synth. Commun.,2006

5. In vitro antioxidant activity of red grape skins;Bartolome;Eur. Food Res. Technol.,2004

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Synthesis, Crystal Structure, DFT Calculations and Optical Properties of Orcinolic Derivatives as OH− Indicators;Crystals;2022-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP